International Brain Tumour Awareness Week - 20-27th October 2018. More info click here.
Category

News archive

IBTA e-News February 2019 now out

[31 February 2019] The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Some of the highlights from this month include the announcement that a “Tumour Monorail” device has been granted ‘breakthrough device’ status…

Read More

IBTA e-News January 2019 now out

[31 January 2019] The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Some of the highlights from this month include the finding of sex differences in glioblastoma tumours, potentially affecting treatment…

Read More

IBTA e-News December 2018 released

[31 December 2018] The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Some of the highlights from this month include the announcement of a $4 million grant for new adult and paediatric brain tumour research projects…

Read More

IBTA e-News November 2018 released

[28 November 2018] The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Some of the highlights from this month include the publication of a major report from the UK Parliament examining the personal financial costs of brain tumours…

Read More

IBTA e-News October 2018 released

[31 October 2018] The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Some of the highlights from this month include encouraging results from a study of a Zika vaccine to target glioblastoma…

Read More

IBTA e-News September 2018 released

[28th September 2018] The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Some of the highlights from this month include the launch of the NCI-CONNECT website, Published brain tumour T-cell therapy research…

Read More

let us know you agree to cookies

The IBTA website uses cookies to give you the best online experience in accordance with our cookies policy. If you are happy, please confirm by clicking the 'Accept' button below.